We have established a cell line from hypertrophied rabbit urinary bladder smooth muscle (SM) that stably expresses SM myosin (SMM). These cells, termed BSM, are spindle-shaped and form swirls, similar to the "hills and valleys" described for cultured aortic SM cells. SDS-PAGE and Western blotting revealed that BSM expresses the N-terminal SMM heavy chain isoform SM-B, the C-terminal SM1 and SM2 isoforms, and SM α-actin. In addition, they express cGMP-dependent protein kinase G, made by contractile SM cells in vitro, but not by non-contractile cells synthesizing extracellular matrix. Immunofluorescence studies indicate a homogeneous population of cells expressing α-actin and SMM, including the SM-B isoform, and karyotyping demonstrates a stable 4N chromosomal pattern. These cells also express calciumdependent myosin light chain kinase and phosphatase activity and contract in response to the muscarinic agonist bethanechol. To our knowledge, BSM is the first visceral SM cell line that expresses the SM-B isoform and might serve as a useful model to study the transcriptional regulation of tissue-specific SMM isoforms in differentiation and pathological SM.
INTRODUCTION
Phenotypic modulation of smooth muscle (SM) cells is associated with various pathological conditions including bladder dysfunction (27, 50) , pulmonary hypertension (38) , atherosclerosis, and restenosis after angioplasty (2) . However, the exact mechanisms underlying the modulation of the SM phenotype in these tissues are not known, despite extensive studies on SM in vivo and in vitro (25, 28, 36, 48) . One factor complicating elucidation of these mechanisms is the heterogeneity of SM cells with respect to myosin isoform expression and other biological properties (24, 49) .
SM cell culture provides an excellent tool to study cellular function provided the cells grown in vitro are capable of expressing the in vivo phenotype. However, cells enzymatically liberated from SM are also heterogeneous and lose their differentiated properties upon culture (6, 11, 29, 45) . Most studies in which cultured bladder myocytes have been used relied only upon the expression of α-smooth muscle actin as a marker for smooth muscle (12, 39, 53) In a study by Kropp et al., smooth muscle myosin expression and contractility were examined in cultured myocytes that had been passaged 2-5 times (32), but they found only a small percentage of the isolated cells staining for smooth m uscle myosin and they did not contract in response to agonists which typically cause bladder smooth muscle tissue contraction (12, 39) .
Several attempts have been made to establish SM cell lines derived primarily from vascular SM (31, 44) . However, Firulli et al. (23) showed two of the major vascular SM cell lines reported to date (PAC1 and A7r5), although retaining expression of α-actin, express virtually no smooth muscle myosin (SMM) mRNA upon passaging. Moreover, karyotyping of both of these cell lines revealed alterations in chromosome number and/or structure (23) .
The two SMM heavy chain isoforms SM-A and SM-B are generated from a single gene through alternative splicing of the pre-mRNA at the 5' end while splicing at the 3' end of this gene produces the SM1 and SM2 heavy chain isoforms (9, 10) . The SM-B isoform contains a 7-amino acid insert in the N-terminal region near the ATP-binding site. This isoform is found in visceral SM and small muscular arteries, but not in large arteries such as the aorta or pulmonary artery which express almost 100% of the SM-A isoform (20) , and has a higher ATPase activity and increased in vitro motility of the myosin (30) (20) as well as increased shortening velocity of the muscle itself (20) compared to the SM-A isoform. A cell line generated from urinary bladder SM, having contained almost entirely SM-B isoform, is likely to provide a homogeneous population of cells with respect to this myosin isoform. Such a population of cells is valuable for studying the transcriptional regulation of the SM-B SMM heavy chain isoform.
SM cells also express an embryonic form of SMM heavy chain known as SMemb which is encoded by a gene distinct from that encoding SMM (33) . This SMemb myosin is expressed at high levels during embryonic development and then decreases dramatically after birth and is expressed at only trace levels in the adult SM (33) . The SMemb isoform has been shown to be identical to the nonmuscle myosin B heavy chain isoform found in brain (47) but distinct from the nonmuscle myosin A (NMA) isoform. Expression of SMemb is upregulated in fetal SM (33) and in adult SM in pathological conditions including atherosclerosis (3) and after vascular stent implantation (2).
In addition to SMM expression, the expression of cGMP-dependent protein kinase (PKG) type I has been suggested another key marker of the SM phenotype (14) . SM cells isolated from rat aorta express high levels of type I PKG. However, upon passaging, PKG levels decrease rapidly such that after several passages its expression is undetectable. This decreased expression of PKG correlates with a switch to a more synthetic phenotype (18) . Moreover, transfection of these passaged cells with cDNA for PKG-1α returns the cells to a contractile phenotype (14) , supporting a role of PKG in maintenance of the SM phenotype. Whereas PKG-1α is expressed abundantly in many different cell types, its alternatively spliced counterpart, PKG-1β, is expressed only in SM.
The contraction of SM is regulated by phosphorylation of the 20 kDa myosin regulatory light chain (LC 20 )(1). The primary enzyme responsible for phosphorylation of SMM is calciumdependent myosin light chain kinase (MLCK) while dephosphorylation of the light chain is accomplished by myosin phosphatase. The phosphatase which is thought to be the major regulator of SM is PP1 which is a multimeric protein consisting of a 37 kDa catalytic subunit, a 21 kDa M21 subunit and a 130/133 kDa (MYPT1) myosin targeting subunit. Thus, for a SM cell to remain contractile it must retain kinase and phosphatase activity. In vivo, bladder smooth must be able to respond to neuronal signals. Stimulation of the muscarinic cholinergic receptor sites by acetylcholine plays a major role in bladder SM contraction and thus the muscarinic agonist bethanechol has widely been used to assess bladder contractility (51).
Here we report a stable SM cell line (BSM), derived from the SM of hypertrophied urinary bladder, that continues to express both α-actin and SMM even after more than 50 passages. These cells also retain expression of PKG, another marker protein for the differentiated SM phenotype, and have a stable chromosome pattern. In addition, BSM cells exhibit calcium-dependent MLCK and phosphatase activity and retain the ability to contract in response to bethanechol. This cell line should prove a valuable tool to study transcriptional regulation of myosin isoforms and the effects of factors or etiological agents that induce pathological changes in SM. In addition, BSM might be a useful source of SM cells for tissue engineering research utilizing rabbits as an animal model and in perfecting the techniques for enhancement of bladder or urethral function in diseases of the lower urinary tract.
METHODS

Partial Outlet Obstruction:
All studies involving animals were approved by the Children's Hospital of Philadelphia and the University of Pennsylvania's animal use committee.
Hypertrophied urinary bladder SM tissue was obtained from a 4-month-old male New Zealand White rabbit with a 2-week partial obstruction of the bladder outlet induced by surgical ligation of the urethra (34) . The bladder from this rabbit, which had developed in vivo urinary bladder dysfunction, was surgically removed under sterile conditions and placed into sterile M199 medium containing 1% nutrient mix and 1% antibiotic-antimycotic (GIBCO BRL; Rockville, MD).
Cell Dissociation and Propagation:
After removal of the mucosa and serosa, bladder body SM from a 2-week partially obstructed rabbit bladder was minced into small pieces (1 x 1 mm) and incubated overnight in M199 medium (GIBCO BRL) with collagenase (1 mg/ml) (GIBCO BRL) to dissociate bladder myocytes. The single cells were collected by centrifugation at 1000 X g at 4°C. The pellet was resuspended and washed in M199 and cultured in nutrient medium [M199 + 10% fetal calf serum (GIBCO BRL) in 60-mm tissue culture dishes (Corning; Action, MA) at 37°C in a humidified atmosphere of 5% CO 2 /95% air. Primary cultures were grown for 2 days and small colonies were picked with a Pasteur pipet and flushed to mechanically dissociate the cells. The dissociated cells were subcultured. This procedure was repeated several times until a stable morphology was obtained, as confirmed by light microscopy. Once cells reached sufficient densities, large-scale amplification was performed in T75 flasks (Corning) and cells were continuously passaged more than 50 times, after brief treatment with trypsin (0.05% trypsin/EDTA) (GIBCO BRL). Cells from various passages were scraped off with a rubber policeman and analyzed for expression of SM-specific proteins by Western blotting and immunofluorescence microscopy. After passage 50, a growth curve was generated. Cells were seeded in 6-well plates (Corning) at an initial density of 4 X 10 4 cells/well in growth medium as described above. Triplicate hemocytometer readings were recorded each day after seeding. NIH 3T3 cells were used as a control for the growth curve.
Immunofluorescence Microscopy: Cells from various passages in M199 medium were grown were separated in mini 7.5% SDS-PAGE gels or in order to separate the SM1 and SM2 SMM isoforms, samples containing equal amounts of total protein (10 µg) were loaded onto highly porous 4.5% (1 mm thick, 16 cm long) polyacrylamide gels and separated by slow electrophoresis overnight at 4°C as previously described (21) . Since SMemb has been shown to comigrate with SM2, similar gels were transferred overnight to Immobilon-P membranes (Millipore; Bedford, MA) as previously described (21) 10 mM imidazole-HCl (pH 7.1), 2 mM ATP. Fifty micrograms of exogenous purified chicken gizzard SMM prepared as described (17) was also added to each assay and the reaction started by adding [γ-32 P]ATP. The reaction was stopped at various times by adding 150 µl of the reaction mix to 1 ml of 10% trichloroacetic acid (TCA)/2% sodium pyrophosphate, the mixture centrifuged at 14,000 X g for 20 min and then the supernatant was dissolved directly in SDS-PAGE sample buffer. The pH was adjusted to neutrality with Tris and the samples separated in a 14% SDS-PAGE gel. The gel was then stained with Coomassie blue and exposed to X-Ray film.
The radiolabeled band representing the LC 20 was then excised from each lane, added to a scintillation vial, crushed with a spatula, mixed with scintillation fluid and counted in a scintillation counter. The protein concentration of the extracts used for the kinase assay were determined by the Bradford assay (15) and then the specific activity of the kinase was calculated as the number of moles phosphate bound to the LC 20 per minute per mg of cell extract protein.
The same assay was conducted in the absence of Ca 2+ with 2 mM EGTA to determine the Ca 2+ dependence of the kinase activity.
Phosphatase Assay: The cell extracts prepared as described under the kinase assay were assayed for phosphatase activity in [5 mM MgCl 2 , 0.1 mM CaCl 2 , 10 mM imidazole-HCl (pH 7.1)].
Purified gizzard myosin phosphorylated using [γ- phosphate. The reaction was stopped by adding TCA to a final concentration of 10% and sodium pyrophosphate to 2% final and the amount of phosphate released per min per mg protein determined by filter binding as previously described (16) .
Cell Contraction Studies:
Muscle cells adhered to glass coverslips coated with rat tail collagen were placed into the temperature controlled recording chamber on an inverted microscope (Nikon TE300, USA). The bath solution consisted of (in mM) 155 NaCl, 4.5 KCl, 2 CaCl 2 , 1
MgCl 2 , 5 glucose, and 10 HEPES and was adjusted to pH 7.4. Bright field images were obtained with an intensified charge coupled video camera (Hammamatsu Model C2400-68, Japan)
connected to the side port of the inverted microscope. Video images were averaged and digitized (0.5 Hz) with a video frame grabber (DVP32, Instrutech Corporation) using Metafluor acquisition and analysis software (Universal Imaging, USA). Stored images were analyzed offline using the Metafluor package. Contraction was induced by bath application of bethanechol (1-100 µM), and relaxation subsequently induced by perfusion with agonist free extracellular solution.
Chromosome Preparation: At passage 50, dissociated cells from the BSM bladder SM cell line were exposed to colcemid for 2-3 hrs, and metaphase arrested chromosome spreads were prepared by standard methodology and stained with Giemsa. A minimum of 20 randomly selected metaphase spreads were photographed and chromosome number and structure were compared to normal rabbit chromosomes. The SM-A and SM-B SMM isoforms differ only by 7 amino acids and thus are not separable by SDS-PAGE. Therefore, Western blot analysis was used to examine SM-B protein expression in BSM. Antibody against the 7-amino acid insert, which is specific for the SM-B isoform (21) , reacted strongly with BSM (Fig. 3B, lanes 1-3) but again to a lesser extent than normal bladder (lane N). Western blot analysis also showed that BSM strongly expresses α-actin (Fig. 3C, lanes 1-3) at levels comparable to those of normal bladder SM (lane N).
RESULTS
Growth
Unlike the normal adult bladder myosin (Fig. 4A, lane N) which separated into the two expected bands for SM1 and SM2 upon slowly running highly porous 4.5% SDS-PAGE gels similar to purified pig bladder myosin (lane P), BSM (lane 1) produced an additional third lower band. Based upon the mobility of this band it appears to represent the nonmuscle myosin A isoform (~ 196 kDa). However, Western blot analysis showed that antibody generated against human nonmuscle myosin A failed to cross-react with the nonmuscle myosin A band as has been reported for other species (7).
Western blot analysis of an identical highly porous gel showed that the two similar bands obtained in both normal bladder and BSM reacted strongly with Sigma antibody that recognizes all SMM isoforms while the third unique band found in BSM did not, confirming that this band is not SMM heavy chain (Fig. 4B) . Interestingly, the cell line (lane 1) expressed slightly more SM2 relative to SM1 comparable to normal bladder (lane N). Since some of the middle SM2 band (in Fig. 4A , lane 1) could also represent SMemb as this myosin has been shown to comigrate with SM2 in SDS-PAGE gels, we also analyzed blots of myosin electrophoresed in highly porous gels using antibody specific for SMemb (a gift from Dr. Robert Adelstein at NIH). Purified myosin ranging from 0.1-3.0 µg was electrophoresed on a 7.5% mini SDS-PAGE gel along with crude extracts of both normal bladder and the BSM cell line containing equal amounts of total myosin heavy chain as predetermined by Coomassie blue staining. The gel was then transferred by Western blotting to membrane and the blot was reacted with the SM-specific Sigma myosin antibody (clone no. hSM-V) that recognizes all SMM isoforms as described in the Methods (Fig. 5) . The purified pig myosin exhibited a linear increase in DAB staining (lanes 1-6) and using this standard curve it was concluded that the BSM cell line (lane C) contains about 30% of the SMM expressed by the normal bladder (lane N) per mg total extractable myosin.
Homogeneity of Myosin and Actin Expression:
Immunofluorescence microscopy using the same antibodies that were used in the Western analysis revealed strong staining of all BSM cells for SM-specific α-actin (Fig. 6A) , while a negative control in which the primary antibody was replaced with mouse pre-immune serum showed only faint staining (Fig. 6B) . A negative control in which the primary antibody was omitted also did not show significant staining (data not shown). Staining of BSM for total SMM was also intense and homogeneous throughout the cells except for the nucleus (Fig. 6C & D) . A similar staining pattern was observed using primary antibody against the SMM heavy chain-specific isoform SM-B (Fig. 6E & F) .
cGMP-Dependent Protein Kinase G (PKG) Expression:
Western blot analysis (Fig. 7 Cell Contraction: Cells from the BSM cell line were grown on collagen-coated coverslips for 2 days and then placed on the stage of an inverted microscope equipped for video photography and washed with the bath solution described in the Methods. No detectable change in cell size or shape was detected after 5 minutes in bath solution (Fig. 9A & D) . Upon addition of 10 µM bethanechol the cells began to contract, but maximum contraction was achieved with 100 µM bethanechol by 1-2 minutes (Fig. 9B & E) demonstrating that these cells maintain the ability to contract in response to agonist that produces contraction in the intact bladder SM strips.
Furthermore, the bethanechol-induced contraction was almost completely reversible within 2 minutes by simply washing the cells with bath solution (Fig. 9C & F) .
Cytogenetic Analysis of the Cell Line:
Chromosome analysis of BSM cells revealed a tetraploidy (4N) with no readily discernable additional morphological differences compared to normal rabbit chromosomes (Fig. 10) . Thus, cells contained 88 chromosomes, twice the number of chromosomes reported for normal rabbit cells (42) .
DISCUSSION
In this study we report the derivation of a stable bladder SM cell line (BSM) that maintains expression of SMM and α-actin along with the ability to contract in response to agonist stimulation. As starting material, we used SM from adult male rabbit urinary bladder wall which was induced to undergo hypertrophy by partial ligation of the urethra (34) . Cells of BSM are capable of large-scale amplification, have now been passaged more than 50 times, maintain a uniform high expression of SM-specific marker proteins (including SMM), and exhibit a seemingly stable tetraploid (4N) chromosomal pattern.
To our knowledge, this is the first report of a SM cell line that expresses smooth muscle myosin, MLCK and myosin phosphatase, and PKG and is contractile in response to physiologic agonist. A unique feature of this cell line is its expression of myosin isoform SM-B which has a high ATPase activity in the presence of actin. The vascular SM cell lines presently available do not express SM-B since they have all been generated from large arteries that do not contain SM-
B (20).
The majority of studies conducted on cultured vascular as well as visceral-type SM cells have relied on expression of α-actin as the major criterion to designate these cells as smooth muscle cells (12, 22, 39, 53) . However, α-actin is not the actin isoform expressed in all SM cells, has been identified in many other cell types including fibroblasts (19) and its expression is actually decreased during development of visceral SM, which expresses predominantly γ-actin (46) . In our study, we focused on the expression of SMM as a marker of the differentiated state of SM because: unlike α-actin, SMM is expressed in all SM cells (52) and its expression is increased in visceral SM during development (7) . Moreover, SMM heavy chain expression appears to be exclusively limited to SM cells (35) .
Our BSM cell line clearly retains strong expression of SMM heavy chain at the protein level based on Western blot and immunofluorescence analyses. For the Western blot analysis of SMM heavy chain, we used a monoclonal antibody that reacts with all four isoforms of myosin (SM1A, SM1B, SM2A, SM2B) and does not cross-react with nonmuscle myosin heavy chain.
This conclusion is based on the fact that both SM1 and SM2 of the bladder, which is predominantly SM-B and thus the isoforms are SM1B and SM2B, react with the Sigma antibody.
The reaction for SM2 is about 3X stronger compared to the SM1 isoform producing a ratio similar to what is found for Coomassie blue staining suggesting that the antibody reacts equally with SM1 and SM2. In addition, we (unpublished data) and others (25) have found that the antibody also reacts equally well with SM1 and SM2 from aorta and since the aorta is almost 100% SM-A the isoforms are SM1A and SM2A.
Thus, it appears that the Sigma antibody does react with all four known isoforms and can used as a measure of total SMM expression. Indeed, no antibody reactivity was observed with NIH3T3 cells in Western blot analysis by us (Fig. 3A) and others (25) . Furthermore, immunofluorescence microscopy using this antibody showed that all the cells in the cultures established from BSM show positive staining (Fig. 6C & D) , indicating the homogeneity of the cell population. Thus, although we cannot be certain that our cell line was derived from a single clone, the phenotype with respect to SMM appears stable. Together, our results demonstrate SMM expression by the BSM cell line at the protein and cellular levels. Preliminary quantification using purified pig bladder SMM as a positive standard revealed that the BSM cell line expressed about 30% of the SMM expressed by normal bladder SM as a percentage of equal amounts of total myosin (Fig. 5 ). This level seems to agree with the lower expression levels of SMM in our gels and Western blots as well (Figs. 3A & B and 4A & B) . The fact that BSM retains expression of PKG and makes both PKG-1α and PKG-1β (expressed only in SM) at the protein level further supports maintenance of the SM phenotype.
The presence of SMemb and nonmuscle myosin A is not surprising, since cells undergoing increased growth are known to express elevated levels of SMemb (4).
Hypertrophied SM from partially obstructed rabbit bladder also exhibits increased expression of nonmuscle myosin A (unpublished data). However, we cannot say with absolute certainty that this band is nonmuscle myosin A since it does not react with the nonmuscle myosin A antibody we used. Our belief that this band is nonmuscle A myosin is based on the fact that it migrates in a position relative to SM1 and SM2 which would predict a size of about 196 kDa (the observed size of nonmuscle myosin A in humans (40) and rats (29, 45) and the fact that others have reported that the antibody to human nonmuscle myosin A does not recognize the sheep nonmuscle myosin A (7).
We showed that the cell line expresses protein for both MLCK and the MYPT1 subunit of myosin phosphatase while the cell extracts revealed activities for both these enzymes. The maximum phosphatase activity obtained is at a level similar to phosphatase activity values reported for normal sheep pulmonary artery (2.0 nmoles/min/mg protein) (13) and normal rabbit basilar artery (3.8 nmoles/min/mg protein) using [γ-32 P] phosphorylase-a as substrate (26) .
Although the MLCK activity is lower than other reported values (13) of the SM cells in the normal rabbit aorta were either 3C or 4C (tetraploid). In human aorta, Printseva et al. (41) found that about 10% of the SM cells in the media and intima of the aorta were tetraploid; interestingly, the number of tetraploid cells increased to about 20% in response to hypertension. A similar increase in polyploidy in response to hypertension was also found in rats and this same study found that increased polyploidy was accompanied by an increase in smooth muscle cell hypertrophy (37) . Therefore, it is not surprising that this cell line, derived from hypertrophied bladder smooth muscle, is tetraploid.
In summary, we have described the isolation of the first SM cell line (BSM) that stably expresses the SMM SM-B isoform and contracts in response to bethanechol. Furthermore, BSM expresses α-actin, MLCK, MYPT1 and PKG. This cell line will provide a valuable tool for studying transcriptional regulation of myosin isoforms and for perfecting tissue engineering in rabbits for urinary bladder augmentation and replacement with tissue engineered bladders (8) Each day a culture was trypsinized and the dissociated cells were counted with a hemocytometer.
FIGURE LEGENDS
Results are the mean of three separate determinations. Doubling time was calculated as approximately 58 hours and cells appeared to reach confluency at 4-5 days. Some of the cells in confluent cultures are arranged in a swirly pattern similar to the "hills and valleys" described for cultured aortic cells. Magnification 100X. Protein extracts containing equal amounts (10 µg) of total extractable protein and purified pig bladder myosin (1 µg) were separated on highly porous 4.5% SDS-PAGE gels as described in SDS-PAGE gels, transferred to Immobilon-P and reacted with antibody specific for PKG as described in Methods. Note that this large gel was able to resolve the PKG-1α and PKG-1β isoforms. 
